BRUNI, COSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.692
EU - Europa 3.725
AS - Asia 3.100
SA - Sud America 428
AF - Africa 71
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.062
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.646
RU - Federazione Russa 1.540
CN - Cina 892
SG - Singapore 824
IT - Italia 719
PL - Polonia 581
HK - Hong Kong 578
BR - Brasile 349
KR - Corea 313
IE - Irlanda 263
SE - Svezia 170
VN - Vietnam 155
DE - Germania 123
IN - India 104
FI - Finlandia 73
FR - Francia 66
ID - Indonesia 56
JO - Giordania 51
AR - Argentina 43
CH - Svizzera 42
AU - Australia 41
GB - Regno Unito 40
CA - Canada 27
NL - Olanda 25
IQ - Iraq 20
TR - Turchia 19
BD - Bangladesh 18
ES - Italia 18
JP - Giappone 15
RO - Romania 15
ZA - Sudafrica 15
CI - Costa d'Avorio 14
MA - Marocco 10
UA - Ucraina 10
CO - Colombia 9
BJ - Benin 8
EC - Ecuador 8
MX - Messico 8
VE - Venezuela 8
PK - Pakistan 7
EG - Egitto 6
PH - Filippine 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
BE - Belgio 5
LT - Lituania 5
PE - Perù 5
AT - Austria 4
HU - Ungheria 4
KE - Kenya 4
NO - Norvegia 4
PA - Panama 4
TW - Taiwan 4
CL - Cile 3
CZ - Repubblica Ceca 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
TH - Thailandia 3
UZ - Uzbekistan 3
BG - Bulgaria 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
IL - Israele 2
IR - Iran 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
PY - Paraguay 2
RS - Serbia 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
BM - Bermuda 1
CG - Congo 1
CY - Cipro 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MR - Mauritania 1
MU - Mauritius 1
NP - Nepal 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TG - Togo 1
TJ - Tagikistan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.062
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.240
Singapore 588
Warsaw 574
Ashburn 546
Hong Kong 509
Fairfield 377
Seoul 310
Hefei 277
Dublin 255
Florence 235
Chandler 226
Woodbridge 201
Beijing 181
Seattle 177
Cambridge 132
Houston 130
Moscow 105
Wilmington 102
Lawrence 95
Altamura 90
Princeton 71
Buffalo 68
Los Angeles 68
Ho Chi Minh City 58
Munich 58
Ann Arbor 57
Boston 57
Mumbai 47
Shanghai 44
Jakarta 41
Kent 40
Melbourne 37
Rome 36
Milan 34
Paris 34
New York 31
Turku 29
Pune 28
Dong Ket 26
Dallas 25
São Paulo 25
Bern 24
The Dalles 24
Chicago 23
Clifton 23
Hanoi 23
Boardman 19
San Diego 19
Naples 18
Medford 17
Redondo Beach 17
Yubileyny 17
Bengaluru 16
Bologna 16
Helsinki 16
Falls Church 15
Abidjan 14
Turin 14
Frankfurt am Main 13
Guangzhou 13
London 13
West Jordan 12
Johannesburg 11
Rio de Janeiro 11
Timisoara 11
Belo Horizonte 10
Fiesole 10
Lappeenranta 10
Norwalk 10
Phoenix 10
Tianjin 10
Toronto 10
Catania 9
Redwood City 9
Andover 8
Brooklyn 8
Cagliari 8
Cotonou 8
Atlanta 7
Barcelona 7
Düsseldorf 7
Pisa 7
Salt Lake City 7
San Francisco 7
Shenzhen 7
Bari 6
Campinas 6
Castelliri 6
Curitiba 6
Denver 6
Jacksonville 6
Montreal 6
Osasco 6
Porto Alegre 6
Ribeirão Preto 6
Siena 6
Tokyo 6
Baghdad 5
Brussels 5
Delhi 5
Totale 7.919
Salva come PNG Salva come JPEG
Nome #
GLI INTERVENTI INFERMIERISTICI RIVOLTI AI PAZIENTI AFFETTI DA MALATTIE REUMATICHE SOTTOPOSTI A TERAPIA CON FARMACI BIOLOGICI: REVISIONE SISTEMATICA DELLA LETTERATURA 335
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 301
Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient. 286
Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis 246
The "myth" of loss of angiogenesis in systemic sclerosis: A pivotal early pathogenetic process or just a late unavoidable event? 218
The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction 215
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 202
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 200
Vascular leaking, a pivotal and early pathogenetic event in systemic sclerosis: should the door be closed? 189
Effect of Dysmetabolisms and Comorbidities on the Efficacy and Safety of Biological Therapy in Chronic Inflammatory Joint Diseases 179
Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis 173
IL CONTRIBUTO DELLA TELEMEDICINA ALLA GESTIONE DEI PAZIENTI REUMATOLOGICI DURANTE LA PANDEMIA DA SARS-CoV-2 172
The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs 172
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease? 172
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 171
Calcinosis in systemic sclerosis: subsets, distribution and complications 170
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study 169
Alfabetizzazione sanitaria e pazienti affetti da Sclerosi Sistemica 167
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 164
Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis 160
The safety of iloprost in systemic sclerosis in a real-life experience 155
A SYSTEMATIC LITERATURE REVIEW (SLR) ON NURSING SENSITIVE OUTCOMES IN SYSTEMIC SCLEROSIS 154
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 154
POS0613 THE ROLE OF MICROBIOTA IN DIFFERENT DISEASE STAGES OF SYSTEMIC SCLEROSIS: A POSSIBLE IMPACT IN GASTROINTESTINAL TRACT DISEASE ACTIVITY? 153
Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis. 153
EFFICACY OF A SELF-TREATMENT PROTOCOL FOR FACE AND TEMPOROMANDIBULAR JOINTS REHABILITATION IN SYSTEMIC SCLEROSIS 151
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 148
Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review 146
THE EXPERIENCE OF A RHEUMATOLOGY UNIT DURING THE COVID19 LOCKDOWN: TELEMEDICINE ALLOWS A SAFE FOLLOW UP OF PATIENTS WITH RHEUMATIC DISEASES 145
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 145
Antioxidant agents help primary Raynaud's phenomenon 144
Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre 144
Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. 142
A systematic review of the literature on nursing sensitive outcomes in scleroderma: towards a structured path led by a nurse case manager 141
Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis 140
Computed Tomography Predictors of Mortality or Disease Progression in Systemic Sclerosis–Interstitial Lung Disease: A Systematic Review 140
Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis 138
Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis 137
Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT 137
Early Detection of Cardiac Involvement in Systemic Sclerosis: The Added Value of Magnetic Resonance Imaging 133
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do? 132
AB1540-HPR NURSING INTERVENTIONS FOR RHEUMATIC MUSCULOSKELETAL DISEASES (RMDS) PATIENTS ON BIOLOGIC THERAPY: A SYSTEMATIC LITERATURE REVIEW (SLR) 131
Quantiferon (QFT) identifies latent tuberculosis (LTB) but does not help the evaluation of the efficacy of prophylaxis in inflammatory arthritides 131
ULTRASOUND (US) EVALUATION OF BOWEL VASCULOPATHY IN SYSTEMIC SCLEROSIS (SSC) 129
Avascular bone necrosis: An underestimated complication of systemic sclerosis 129
Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases 129
DECIPHERING THE GUT MICROBIOTA OF VERY EARLY SYSTEMIC SCLEROSIS (VEDOSS) PATIENTS: A TAXONOMIC AND FUNCTIONAL CHARACTERIZATION 127
Prognostic value of lung ultrasound B-lines in systemic sclerosis 126
The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review 125
Lung ultrasound B-lines in systemic sclerosis: cut-off values and methodological indications for interstitial lung disease screening 125
Patient preferences for systemic sclerosis treatment: A descriptive study within an Italian cohort 120
The renal resistive index: A new biomarker for the follow-up of vascular modifications in systemic sclerosis 120
ASSESSMENT OF HEALTH LITERACY IN A COHORT OF SYSTEMIC SCLEROSIS (SSC) PATIENTS 120
Combination therapy with Bosentan and Sildenafil improves Raynaud’s phenomenon and fosters the recovery of microvascular involvement in systemic sclerosis 119
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life 119
Oral lactobacillus species in systemic sclerosis 118
Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study 116
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience 116
The Use and Utility of Machine Learning in Achieving Precision Medicine in Systemic Sclerosis: A Narrative Review 115
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database 114
Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis. 114
The multifaceted problem of pulmonary arterial hypertension in systemic sclerosis 111
Ultrashort Echo-Time Magnetic Resonance Imaging Sequence in the Assessment of Systemic Sclerosis-Interstitial Lung Disease 110
Very early versus early disease: the evolving definition of the 'many faces' of systemic sclerosis. 109
Serum Organ-Specific Anti-Heart and Anti-Intercalated Disk Autoantibodies as New Autoimmune Markers of Cardiac Involvement in Systemic Sclerosis: Frequency, Clinical and Prognostic Correlates 109
Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS) 109
The role of ultrasound in systemic sclerosis: On the cutting edge to foster clinical and research advancement 109
Stressful life events at the onset and during the evolution of systemic sclerosis 108
Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic Sclerosis 107
Hydroxychloroquine and joint involvement in systemic sclerosis: Preliminary beneficial results from a retrospective case-control series of an EUSTAR center 107
Lung magnetic resonance imaging in systemic sclerosis: a new promising approach to evaluate pulmonary involvement and progression 106
Treatment of ulcers in systemic sclerosis 105
The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature review 104
Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis. 104
Recent advances steer the future of systemic sclerosis toward precision medicine 103
Systemic sclerosis and primary biliary cholangitis: Longitudinal data to determine the outcomes 101
Nursing interventions for patients with rheumatic and musculoskeletal diseases on biological therapies: a systematic literature review 92
Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profile 89
Lung vascular changes as biomarkers of severity in systemic sclerosis–associated interstitial lung disease 87
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management 87
Digital Ulcers in Systemic Sclerosis 87
To develop a definition and validated expert recommendations to diagnose primary heart involvement in systemic sclerosis - preliminary pathway to a T2T approach 85
Switching from rituximab originator to GP2013 or CT-P10 biosimilars in autoimmune rheumatic diseases: drug retention rate and safety data from a multicentric retrospective cohort 82
The Role of Bronchoalveolar Lavage in Systemic Sclerosis Interstitial Lung Disease: A Systematic Literature Review 77
Very early and early diagnosis of systemic sclerosis 76
Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study 76
Kidney involvement in systemic sclerosis: From pathogenesis to treatment 68
Towards a comprehensive approach to the management and prognosis of systemic sclerosis's patients: The role of comorbidities in the SPRING-SIR registry 62
The emerging challenge of pain in systemic sclerosis: Similarity to the pain experience reported by Sjőgren’s syndrome patients 61
Patients and physicians differently consider severity and outcomes of systemic sclerosis-associated interstitial lung disease: Results of an international survey 56
First‐line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING‐SIR registry 10
Gastrointestinal involvement in very early and established systemic sclerosis: insights from the SPRING-SIR national Italian registry 9
Ultrasound evaluation of bowel vasculopathy in systemic sclerosis 4
Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry 2
Menopause in systemic sclerosis: the impact on clinical presentation in a multicenter cross-sectional analysis from the National Registry of the Italian Society for Rheumatology (SPRING-SIR) 2
Totale 12.250
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.781
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.781
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021471 0 0 0 0 0 70 82 57 75 100 39 48
2021/2022432 12 20 32 20 25 46 8 41 19 27 62 120
2022/20231.168 109 285 61 62 61 169 165 39 102 19 50 46
2023/2024867 21 74 97 50 60 134 50 154 22 113 64 28
2024/20254.509 140 439 254 731 1.089 515 216 380 193 144 179 229
2025/20263.096 622 703 555 514 671 31 0 0 0 0 0 0
Totale 12.250